GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 2.332
AS - Asia 1.869
EU - Europa 899
SA - Sud America 337
AF - Africa 45
OC - Oceania 14
Totale 5.496
Nazione #
US - Stati Uniti d'America 2.231
SG - Singapore 789
IT - Italia 322
CN - Cina 301
BR - Brasile 265
VN - Vietnam 252
HK - Hong Kong 175
DE - Germania 159
GB - Regno Unito 72
ID - Indonesia 65
IN - India 64
JP - Giappone 63
FR - Francia 49
CA - Canada 44
MX - Messico 44
FI - Finlandia 42
NL - Olanda 42
PL - Polonia 42
RU - Federazione Russa 39
AR - Argentina 35
BD - Bangladesh 25
TR - Turchia 21
SE - Svezia 19
ES - Italia 18
ZA - Sudafrica 17
IQ - Iraq 16
AT - Austria 15
AU - Australia 14
AE - Emirati Arabi Uniti 12
UA - Ucraina 12
PK - Pakistan 11
CO - Colombia 9
EC - Ecuador 9
SA - Arabia Saudita 9
MY - Malesia 8
PH - Filippine 8
RO - Romania 8
CH - Svizzera 7
LT - Lituania 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EG - Egitto 6
IE - Irlanda 6
CR - Costa Rica 5
GR - Grecia 5
KR - Corea 5
TH - Thailandia 5
VE - Venezuela 5
BE - Belgio 4
DK - Danimarca 4
HU - Ungheria 4
NG - Nigeria 4
UY - Uruguay 4
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KG - Kirghizistan 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
Totale 5.490
Città #
Singapore 494
Ashburn 415
San Jose 261
Hong Kong 170
Santa Clara 169
Chandler 127
Dallas 108
Beijing 95
New York 90
Ho Chi Minh City 87
Munich 85
Los Angeles 79
Council Bluffs 75
Tokyo 61
Hanoi 60
Jakarta 53
Milan 53
Fairfield 45
Warsaw 41
Lauterbourg 36
Shanghai 35
São Paulo 33
Ferrara 32
Houston 28
Mexico City 28
Bologna 26
Addison 23
Chicago 23
London 22
Bremen 21
Chennai 21
Princeton 21
Rome 21
Denver 19
Helsinki 18
Toronto 18
Hefei 17
Orem 17
The Dalles 17
Atlanta 16
Buffalo 15
Seattle 15
Cambridge 14
San Francisco 14
Turku 14
Phoenix 13
Amsterdam 12
Frankfurt am Main 12
Manchester 12
Wilmington 12
Modena 11
Montreal 11
San Diego 11
Brooklyn 10
Stockholm 10
Boston 9
Da Nang 9
Haiphong 9
Lappeenranta 9
New Delhi 9
Rio de Janeiro 9
Woodbridge 9
Falkenstein 8
Moscow 8
Poplar 8
Sydney 8
Ann Arbor 7
Boardman 7
Casalecchio Di Reno 7
Hải Dương 7
Mumbai 7
Ankara 6
Baghdad 6
Charlotte 6
Kuala Lumpur 6
Naples 6
Brasília 5
Buenos Aires 5
Columbus 5
Guarulhos 5
Hillsboro 5
Johannesburg 5
Nuremberg 5
Ottawa 5
Paris 5
Portland 5
Salt Lake City 5
Thái Nguyên 5
Vienna 5
Washington 5
Assago 4
Barnet 4
Brno 4
Bến Tre 4
Cairo 4
Campinas 4
Casablanca 4
Dhaka 4
Dublin 4
Florence 4
Totale 3.516
Nome #
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 206
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 187
A tool to predict survival in stage IV entero-pancreatic NEN 186
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 173
Functional hypothalamic and drug-induced amenorrhea: an overview 169
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 168
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 165
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 163
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 159
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 156
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 153
Acromegaly in the elderly patients 152
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 148
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 148
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 147
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 142
Craniopharyngioma and Eating Disorders 139
Bone health in adolescence 138
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 137
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 133
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 130
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 129
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 129
Long-term low-dose tolvaptan efficacy and safety in SIADH 128
Iperprolattinemia: vecchie e nuove insidie diagnostiche 126
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 124
Hypeprolactinemia: still an insidious diagnosis 122
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 122
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 117
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 114
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 112
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 103
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 102
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 99
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 90
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 89
I livelli di colesterolo LDL sono associati alla secrezione insulinica 89
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 83
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 73
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 73
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 73
L’acromegalia nell’anziano 69
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 64
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) [Neuroendocrine Neoplasms prognostic markers] 57
Acromegalia: differenze di sesso e genere [Sex and gender differences in acromegaly] 43
Totale 5.629
Categoria #
all - tutte 30.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 816
Totale 31.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 8 7
2021/2022166 9 4 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/20251.264 43 50 96 52 138 138 60 54 217 118 162 136
2025/20263.447 348 131 319 418 554 226 408 229 298 407 109 0
Totale 5.629